- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02841059
The Pelvic Floor Function and Sexual Life of the Women After Different Type of Hysterectomy (HYS-PF-QOL)
February 22, 2017 updated by: Buddhist Tzu Chi General Hospital
The Association of Total Hysterectomy and Disorders of Female Pelvic Floor or Sexual Function: a Survey on Pelvic Floor Function and Sexual Life for Women After Different Type of Hysterectomy
In this prospective, comparative non-randomized multiple teaching hospitals study, the investigators try to determine the relationship of total hysterectomy and Taiwanese female pelvic floor and sexual function from the view of epidemiology and clinical survey.
This is an important issue that related to female autonomy, health care resources and even national health policy.
The study results will help to understand whether there is unnecessary part in the current hysterectomy procedures and its potential health hazard.
Study Overview
Status
Unknown
Intervention / Treatment
Detailed Description
Women with benign gynecology disease and indicated for laparoscopic hysterectomy (laparoscopic subtotal hysterectomy: LSH, laparoscopic cervical ligament sparing hysterectomy: CLSH, laparoscopic assisted vaginal hysterectomy: LAVH) are invited and explained the details of the protocol by the surgeon.
The types of hysterectomy are determined by the patient and the surgeon together after discussion.
All participant have to sign the informed consent.
The participant will be followed up for two years after surgery.
Preoperative evaluation on uterine condition, pelvic floor, questionaires were recorded.
The perioperative parameters including surgical time, blood loss, and postoperative parameters such as pain score, hospitalization etc were recorded.
The postoperative evaluation on pelvic floor condition, questionaires etc were also recorded at different time points.
Study Type
Observational
Enrollment (Anticipated)
120
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Chiayi, Taiwan, 62224
- Dalin Tzu Chi Hospital
-
Hualien, Taiwan, 970
- Buddhist Tzu Chi General Hospital
-
Hualien, Taiwan, 970
- Mennonite Memorial Hospital
-
Taipei, Taiwan, 23142
- Taipei Tzu Chi Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
30 years to 50 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Sampling Method
Non-Probability Sample
Study Population
Patient who is indicated for hysterectomy due to benign gynecology disease.
The participant's husband is also welcomed to join the survey of the sexual life questionnaire but this is not a necessary inclusion criteria.
Description
Inclusion Criteria:
- Patient who is indicated for hysterectomy due to benign gynecology disease. The participant's husband is also welcomed to join the survey of the sexual life questionnaire but this is not a necessary inclusion criteria.
Exclusion Criteria:
- Suspect of or diagnosed as cancer patient
- Age < 30 or > 50 years old
- Menopausal woman or woman who is nulliparous
- Patient with advanced pelvic floor prolapse (stage 2, 3, 4) including uterine prolapse, cystocele, enterocele, rectocele.
- Patient with prominent urinary incontinence that affect social activity or suggested to have surgery by gynecologist or urologist.
- Patient with severe medical diseases such as liver cirrhosis, heart failure, poor control diabetes mellitus etc.
- Patient with severe pelvic inflammatory disease/tubo-ovarian abcess or pelvic endometriosis or history of severe pelvic adhesions.
- Psychiatric patients
- Patient with chronic lung disease such as bronchial asthma, bronchiectasis, chronic obstructive pulmonary disease and interstitial lung disease
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Case-Control
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Laparoscopic subtotal hysterectomy
women with benign gynecology disease and decided to receive laparoscopic subtotal hysterectomy (LSH) after discussion with her surgeon.
|
laparoscopic subtotal hysterectomy: LSH
Other Names:
|
Laparoscopic CLSH
women with benign gynecology disease and decided to receive laparoscopic cervical ligament sparing hysterectomy (CLSH) after discussion with her surgeon.
|
laparoscopic cervical ligament sparing hysterectomy: CLSH
|
Laparoscopic AVH
women with benign gynecology disease and decided to receive laparoscopic assisted vaginal hysterectomy (LAVH) after discussion with her surgeon.
|
laparoscopic assisted vaginal hysterectomy: LAVH
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Quality of life change
Time Frame: up to 12 months after hysterectomy
|
Evaluate the change of quality of life by questionaire --WHOQOL-BREF Taiwan version, at preoperation,1,3,6 and 12 months after hysterectomy.
|
up to 12 months after hysterectomy
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Pelvic organ prolapse change
Time Frame: up to 24 months after hysterectomy
|
evaluate by Pelvic Organ Prolapse Quantification System (POP-Q) at preoperation, 6,12 and 24 months after hysterectomy.
|
up to 24 months after hysterectomy
|
Urinary disorders change
Time Frame: preoperation and 3,6 and 12 months after hysterectomy
|
evaluate by UDI-6 short form at preoperation,3,6 and 12 months after hysterectomy.
|
preoperation and 3,6 and 12 months after hysterectomy
|
Sexual life change
Time Frame: preoperation and 3,6 and 12 months after hysterectomy
|
short form of PISQ-9 approved by International Urogynecological Association, IUGA, at preoperation,3,6 and 12 months after hysterectomy.
|
preoperation and 3,6 and 12 months after hysterectomy
|
Urinary incontinence status change
Time Frame: preoperation and 3,6 and 12 months after hysterectomy
|
evaluate by IIQ-7 short form at preoperation,3,6 and 12 months after hysterectomy.
|
preoperation and 3,6 and 12 months after hysterectomy
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Investigators
- Principal Investigator: Mun-Kun Hong, MD, Department of Obstetrics and gynecology
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
May 1, 2015
Primary Completion (Anticipated)
June 1, 2017
Study Completion (Anticipated)
June 1, 2018
Study Registration Dates
First Submitted
June 20, 2016
First Submitted That Met QC Criteria
July 19, 2016
First Posted (Estimate)
July 21, 2016
Study Record Updates
Last Update Posted (Actual)
February 23, 2017
Last Update Submitted That Met QC Criteria
February 22, 2017
Last Verified
July 1, 2016
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- HYS-SEX-QOL-POP
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Undecided
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Quality of Life
-
Assiut UniversityUnknownImproving Quality of LifeEgypt
-
B. Braun Medical SAUnknownQuality of Life of Colostomized Patient
-
Children's National Research InstituteRecruitingProfessional Quality of LifeUnited States
-
Istituto Ortopedico RizzoliUniversity of BolognaRecruitingImprove Quality of LifeItaly
-
Mattu UniversityCompletedBreif Description: Patients' Quality of Life ofEthiopia
-
University of South CarolinaNational Institute on Minority Health and Health Disparities (NIMHD)RecruitingHealth Related Quality of LifeUnited States
-
PharmanexSprim Advanced Life SciencesCompletedHealth-related Quality of LifeUnited States
-
Region VästmanlandUnknownHealth Related Quality of Life
-
Ain Shams UniversityCompletedHealth Related Quality of LifeEgypt
-
Institute of Oncology LjubljanaUnknownHealth-related Quality of LifeSlovenia
Clinical Trials on LSH
-
Oslo University HospitalCompleted
-
Szabocsik and Associates, Inc.Completed